Efficacy and tolerability of rituximab and reduced-dose cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy for elderly patient with diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

Efficacy and tolerability of rituximab and reduced-dose cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy for elderly patient with diffuse large B-cell lymphoma

Published:2018-08-11 Issue:1 Volume:24 Page:52-59
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Kayamori Kensuke¹²,Shono Katsuhiro¹,Onoda Masahiro¹,Yokota Akira¹

Affiliation:

1. Department of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan

2. Department of Hematology, Chiba University Hospital, Chiba, Japan

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://tandfonline.com/doi/pdf/10.1080/10245332.2018.1509461

Reference21 articles.

1. Cancer in older persons: an international issue in an aging world

2. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

3. Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin’s lymphoma: results from the NHL-B trial of the GermanHigh-Grade Non-Hodgkin’s Lymphoma Study Group (DSHNHL)

4. The effect of optimal treatment on elderly patients with aggressive non-Hodgkin's lymphoma: more patients treated with unaffected response rates

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determination of the appropriate chemotherapy for patients aged 80 years or older with diffuse large B cell lymphoma;2024-06-12

2. Use of R-mini-CHP in combination with polatuzumab vedotin (pola-R-mini-CHP) as the primary treatment in ≥80-year-old cases with diffuse large B-cell lymphoma;Journal of Clinical and Experimental Hematopathology;2023-12-26

3. BR vs. R‑miniCHOP in unfit patients with B‑cell non‑Hodgkin lymphoma: A randomized, two‑center, cohort study;Oncology Letters;2023-08-23

4. Bendamustine plus Rituximab versus R-miniCHOP: which is better for unfit patients with diffuse larger B-cell lymphoma?;Journal of Chemotherapy;2023-06-04

5. Impact of therapeutic management and geriatric evaluation on patient of eighty years and older with diffuse large B‐cell lymphoma on survival: A systematic review;European Journal of Haematology;2021-09-21